p chk2 (Cell Signaling Technology Inc)
Structured Review

P Chk2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 545 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+chk2/Phospho-Chk2+(Thr68)+Rabbit+mAb/pmc12990383-20-0-2
Average 96 stars, based on 545 article reviews
Images
1) Product Images from "SKA2 promotes gastric cancer progression by regulating glutathione metabolism"
Article Title: SKA2 promotes gastric cancer progression by regulating glutathione metabolism
Journal: iScience
doi: 10.1016/j.isci.2026.115202
Figure Legend Snippet: Knocking down SKA2-induced cell-cycle arrest and apoptosis through the SKA2/ROS/ATM axis in GC cell lines (A) Western blotting analysis of γ-H2AX (Ser139), ATM, p -ATM (Ser1981), p -Chk2 (Thr68), and SKA2 expression in SNU638 and NUGC3 SKA2-knockdown cell lines. (B) Western blotting analysis of SKA2 overexpression in SNU638 and NUGC3 SKA2-knockdown cell lines using antibodies against γ-H2AX (Ser139), ATM, p -ATM (Ser1981), p -Chk2 (Thr68), and SKA2. (C) Western blotting analysis of KU-55933 treatment in SNU638 and NUGC3 SKA2-knockdown cell lines using antibodies against cyclin D1, cyclin A2, cyclin B1, p -Chk2 (Thr68), PARP, Cleaved-Caspase3, JNK, p -JNK (Thr183/Tyr185), ATM, p -ATM (Ser1981), and SKA2. (D) Western blotting analysis of BML-277 treatment in SNU638 and NUGC3 SKA2-knockdown cell lines using antibodies against cyclin D1, cyclin A2, cyclin B1, p -Chk2 (Thr68), and SKA2. (E) Western blotting analysis of P38, p-P38 (Thr180/Tyr182), ERK, p -ERK1/2 (Thr202/Tyr204), JNK, p -JNK (Thr183/Tyr185), and SKA2 expression in SNU638 and NUGC3 SKA2-knockdown cell lines. (F) Western blotting analysis of the rescue effect of SKA2 overexpression on MAPK pathway markers (ERK, p -ERK1/2, JNK, and p -JNK) in SNU638 and NUGC3 SKA2-knockdown cell lines. (G) Western blotting analysis of JNK-IN-8 treatment in SNU638 SKA2-knockdown cell lines using antibodies against PARP, cleaved-caspase3, JNK, p -JNK (Thr183/Tyr185), and SKA2. α-Tubulin was used as the internal control for all blots. Representative blotting images are shown from 3 independent experiments.
Techniques Used: Western Blot, Expressing, Knockdown, Over Expression, Control
Related Articles
Western Blot:Article Title: Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition Article Snippet: .. Primary antibodies for immunoblots were: phospho-Histone H2A.X (Ser139)(20E3) (Cell Signaling Technology #9718; RRID:AB_2118009); ATM (D2E2) (Cell Signaling Technology #2873; RRID:AB_2062659); Phospho-ATM (Ser1981)(D6H9)( Cell Signaling Technology #5883; RRID:AB_10835213); MRE11 (31H4)(Cell Signaling Technology #4847; RRID:AB_10693469); phospho-MRE11 (Ser676)(Cell Signaling Technology #4859; RRID:AB_2145096); p95/NBS1 (NBN) (D6J5I)(Cell Signaling Technology #14956; RRID:AB_2798660); phospho-p95/NBS1 (NBN)(Ser343)(Cell Signaling Technology #3001; RRID:AB_10829154); Rad50 (Cell Signaling Technology #3427; RRID:AB_2176936); phospho-CHK1 (Ser345)(133D3)(Cell Signaling Technology #2348; RRID:AB_331212); Article Title: Circular RNA circATM binds PARP1 to suppress Wnt/β-catenin signaling and induce cell cycle arrest in gastric cancer cells Article Snippet: The following antibodies were used in the Co-IP assay: anti-FLAG M2 antibody (Sigma-Aldrich Cat# F1804, RRID:AB_262044), anti-PARP1 antibody (Proteintech Cat# 66520-1-Ig, RRID:AB_2881883), anti-β-catenin antibody (Cell Signaling Technology Cat# 8480, RRID:AB_11127855), rabbit IgG (Cell Signaling Technology Cat# 3900, RRID:AB_1550038), and mouse IgG (Cell Signaling Technology Cat# 5415, RRID:AB_10829607). .. Antibodies targeting the following markers were used for western blotting: PARP (Cell Signaling Technology Cat# 9542, RRID:AB_2160739), Survivin (Cell Signaling Technology Cat# 2808, RRID:AB_2063948), Cox2 (Cell Signaling Technology Cat# 4842, RRID:AB_2084968), APC (Cell Signaling Technology Cat# 2504, RRID:AB_2057484), AXIN2 (Cell Signaling Technology Cat# 5863, RRID:AB_10835211), TCF4 (Cell Signaling Technology Cat# 2953, RRID:AB_2199265), p16 (Cell Signaling Technology Cat# 92803, RRID:AB_2750891), p21 (Cell Signaling Technology Cat# 2947, RRID:AB_823586), p27 (Cell Signaling Technology Cat# 3686, RRID:AB_2077850), CDK2 (Cell Signaling Technology Cat# 2546, RRID:AB_2276129), cyclin A2 (Cell Signaling Technology Cat# 4656, RRID:AB_2071958), ATM (Cell Signaling Technology Cat# 2873, RRID:AB_2062659), phospho-ATM (Ser1,981) (Cell Signaling Technology Cat# 4526, RRID:AB_2062663), Chk1 (Cell Signaling Technology Cat# 2360, RRID:AB_2080320), phospho-Chk1 (Cell Signaling Technology Cat# 2348, RRID:AB_331212), Chk2 (Cell Signaling Technology Cat# 6334, RRID:AB_11178526), Article Title: Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides Article Snippet: .. Samples were subjected to electrophoresis and western analysis using 1:1000 dilutions of phospho-ATM (S1981, Cell Signaling, #4526), ATM (Abcam, #ab78), other:Article Title: GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors Article Snippet: Article Title: TTI1 contributes to radioresistance by activating ATM pathway in rectal cancer. Article Snippet: Antibodies against Bcl-2(D17C4)(3498), Bax(D2E11) (5023), Chk2(D9C6)(6334), Phospho-Chk2(Thr68) (C13C1)(2197) and pan-Acetylated-Lysine( Electrophoresis:Article Title: Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides Article Snippet: .. Samples were subjected to electrophoresis and western analysis using 1:1000 dilutions of phospho-ATM (S1981, Cell Signaling, #4526), ATM (Abcam, #ab78), |
